From Mitochondria to Protein Degradation: Mike Kiebish on BPGbio’s "Biology First" Vision

This is a free preview of a paid episode. To hear more, visit www.mendelspod.com

As artificial intelligence continues to influence the life sciences, some researchers are questioning not just what it can predict, but what it can explain. On this episode, Mike Kiebish, VP of Platform and Translational Sciences at BPGbio, discusses the company’s “biology-first” approach to drug discovery—one that begins not with models or literature, …